Hemogenyx Pharmaceuticals Plc

LSE (GBp): Hemogenyx Pharmaceuticals Plc (HEMO)

Last Price

834.00

Today's Change

+304.00 (57.35%)

Day's Change

556.00 - 990.00

Trading Volume

660,805

Overview

Market Cap

43 Million

Shares Outstanding

4 Million

Avg Volume

65,181

Avg Price (50 Days)

168.59

Avg Price (200 Days)

249.75

PE Ratio

-5.03

EPS

-1.81

Earnings Announcement

25-Sep-2025

Previous Close

530.00

Open

600.00

Day's Range

556.0 - 990.0

Year Range

124.0 - 1200.0

Trading Volume

725,488

Price Change Highlight

1 Day Change

71.70%

5 Day Change

365.47%

1 Month Change

489.95%

3 Month Change

416.31%

6 Month Change

189.35%

Ytd Change

117.13%

1 Year Change

72.35%

3 Year Change

51.67%

5 Year Change

-80.47%

10 Year Change

-99.84%

Max Change

-99.84%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment